Stock OHI OMEGA HEALTHCARE INVESTORS, INC.
Add to a list
To use this feature you must be a member
Log inSign up
PDF Report : Omega Healthcare Investors, Inc.

Financials Omega Healthcare Investors, Inc.

Equities

OHI

US6819361006

Specialized REITs

Market Closed - Nyse
Other stock markets
 04:00:01 2023-12-01 pm EST 		Intraday chart for Omega Healthcare Investors, Inc. 5-day change 1st Jan Change
32.12 USD +1.17% +0.28% +14.92%
Nov. 27 Wells Fargo Adjusts Price Target on Omega Healthcare Investors to $33 From $34, Maintains Equal-Weight Rating MT
Nov. 07 North American Morning Briefing : Higher Bond -2- DJ

Valuation

Fiscal Period : December 2018 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 7 054 9 254 8 245 7 071 6 545 7 869 - -
Enterprise Value (EV) 1 11 585 14 366 13 251 12 304 11 535 12 743 12 964 13 096
P/E ratio 25,1x 26,8x 51,9x 16,9x 15,5x 28,8x 22,1x 21,5x
Yield 7,51% 6,26% 7,38% 9,06% 9,59% 8,34% 8,37% 8,34%
Capitalization / Revenue 9,19x 11,7x 11,1x 7,76x 8,91x 9,56x 9,01x 8,72x
EV / Revenue 15,1x 18,2x 17,9x 13,5x 15,7x 15,5x 14,8x 14,5x
EV / EBITDA 14,2x 16,8x 16,2x 12,5x 14,5x 14,1x 13,5x 12,7x
EV / FCF - - - - - - - -
FCF Yield - - - - - - - -
Price to Book 2,06x 2,27x - 1,81x 1,72x - - -
Nbr of stocks (in thousands) 200 697 218 502 227 004 238 974 234 183 244 994 - -
Reference price 2 35,2 42,4 36,3 29,6 28,0 32,1 32,1 32,1
Announcement Date 11/02/19 05/02/20 04/02/21 02/02/22 02/02/23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period : December 2018 2019 2020 2021 2022 2023 2024 2025
Net sales 1 767 791 741 911 734 823 874 903
EBITDA 1 818 856 820 986 793 903 961 1 032
EBIT 1 473 552 490 644 461 519 614 652
Operating Margin 61,6% 69,7% 66,2% 70,7% 62,8% 63,1% 70,2% 72,2%
Earnings before Tax (EBT) 1 297 344 162 416 436 282 375 428
Net income 1 282 341 159 417 427 272 364 384
Net margin 36,7% 43,1% 21,5% 45,8% 58,1% 33,1% 41,6% 42,6%
EPS 2 1,40 1,58 0,70 1,75 1,80 1,11 1,45 1,50
Free Cash Flow - - - - - - - -
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 2,64 2,65 2,68 2,68 2,68 2,68 2,69 2,68
Announcement Date 11.02.19 05.02.20 04.02.21 02.02.22 02.02.23 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period : December 2021 Q2 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4
Net sales 1 218 244 214 213 208 203 110 185 215 206 209 220 221 224 226
EBITDA 1 239 263 229 229 222 217 125 194 224 218 231 236 241 248 253
EBIT 1 153 177 144 147 139 134 41,1 75,6 142 137 141 147 150 158 159
Operating Margin 70,4% 72,6% 67,0% 68,7% 67,0% 66,1% 37,3% 40,8% 66,1% 66,6% 67,4% 66,9% 67,7% 70,5% 70,5%
Earnings before Tax (EBT) 1 86,6 142 33,7 195 91,3 102 48,0 34,7 62,1 97,0 80,8 89,6 92,7 97,5 98,8
Net income 1 84,5 139 33,3 190 89,5 102 45,6 35,9 59,9 91,4 88,2 86,9 90,6 94,1 95,9
Net margin 38,8% 57,0% 15,5% 88,9% 43,1% 50,3% 41,4% 19,4% 27,8% 44,4% 42,1% 39,5% 41,0% 42,1% 42,5%
EPS 2 0,36 0,58 0,14 0,79 0,38 0,43 0,19 0,15 0,25 0,37 0,35 0,34 0,35 0,37 0,38
Dividend per Share 2 0,67 0,67 0,67 0,67 0,67 0,67 0,67 0,67 0,67 - 0,67 0,67 0,67 0,67 0,67
Announcement Date 08/02/21 11/04/21 02/02/22 05/02/22 08/01/22 11/02/22 02/02/23 05/02/23 08/02/23 11/02/23 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period : December 2018 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 4 530 5 112 5 006 5 233 4 990 4 874 5 095 5 227
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 5,54x 5,97x 6,10x 5,31x 6,29x 5,40x 5,30x 5,07x
Free Cash Flow - - - - - - - -
ROE (net income / shareholders' equity) 9,16% 10,3% 3,99% 10,8% 11,4% 6,97% 10,8% 12,5%
Shareholders' equity 1 3 075 3 306 3 989 3 874 3 758 3 904 3 358 3 083
ROA (Net income/ Total Assets) 3,69% 4,25% - - - - - -
Assets 1 7 628 8 019 - - - - - -
Book Value Per Share 17,0 18,6 - 16,3 16,2 - - -
Cash Flow per Share - - - 2,96 2,56 - - -
Capex 1 - - - - - 510 500 400
Capex / Sales - - - - - 62,0% 57,2% 44,3%
Announcement Date 02/11/19 02/05/20 02/04/21 02/02/22 02/02/23 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Omega Healthcare Investors, Inc.

Trading Rating :
Investor Rating :
ESG Refinitiv :
B
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
32.12USD
Average target price
33.33USD
Spread / Average Target
+3.78%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Healthcare REITs

1st Jan change Capi.
OMEGA HEALTHCARE INVESTORS, INC. Stock Omega Healthcare Investors, Inc.
+14.92% 7 869 M $
WELLTOWER INC. Stock Welltower Inc.
+36.48% 49 513 M $
VENTAS, INC. Stock Ventas, Inc.
+3.80% 18 802 M $
HEALTHPEAK PROPERTIES, INC. Stock Healthpeak Properties, Inc.
-27.40% 9 957 M $
HEALTHCARE REALTY TRUST INCORPORATED Stock Healthcare Realty Trust Incorporated
-20.76% 5 999 M $
MEDICAL PROPERTIES TRUST, INC. Stock Medical Properties Trust, Inc.
-53.23% 3 118 M $
AEDIFICA SA Stock Aedifica SA
-22.89% 3 019 M $
PHYSICIANS REALTY TRUST Stock Physicians Realty Trust
-15.55% 2 910 M $
CARETRUST REIT, INC. Stock CareTrust REIT, Inc.
+23.14% 2 725 M $
COFINIMMO Stock Cofinimmo
-21.80% 2 612 M $
Healthcare REITs
  1. Stock
  2. Equities
  3. Stock Omega Healthcare Investors, Inc. - Nyse
  4. Financials Omega Healthcare Investors, Inc.
The best tools reserved for subscribers to boost the performance of your investments!
Optimize my profits
fermer